202 related articles for article (PubMed ID: 24619071)
1. Reasons for non-uptake and subsequent participation in the NHS Bowel Cancer Screening Programme: a qualitative study.
Palmer CK; Thomas MC; von Wagner C; Raine R
Br J Cancer; 2014 Apr; 110(7):1705-11. PubMed ID: 24619071
[TBL] [Abstract][Full Text] [Related]
2. Reasons for non-participation in the Northern Ireland Bowel Cancer Screening Programme: a qualitative study.
Bradley DT; Treanor C; McMullan C; Owen T; Graham A; Anderson D
BMJ Open; 2015 Sep; 5(9):e008266. PubMed ID: 26353870
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme.
Lo SH; Halloran S; Snowball J; Seaman H; Wardle J; von Wagner C
Gut; 2015 Feb; 64(2):282-91. PubMed ID: 24812001
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
Murphy J; Halloran S; Gray A
BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
[TBL] [Abstract][Full Text] [Related]
5. Cognitive ability and personality as predictors of participation in a national colorectal cancer screening programme: the English Longitudinal Study of Ageing.
Gale CR; Deary IJ; Wardle J; Zaninotto P; Batty GD
J Epidemiol Community Health; 2015 Jun; 69(6):530-5. PubMed ID: 25648994
[TBL] [Abstract][Full Text] [Related]
6. Reducing the socioeconomic gradient in uptake of the NHS bowel cancer screening Programme using a simplified supplementary information leaflet: a cluster-randomised trial.
Smith SG; Wardle J; Atkin W; Raine R; McGregor LM; Vart G; Morris S; Duffy SW; Moss S; Hackshaw A; Halloran S; Kralj-Hans I; Howe R; Snowball J; Handley G; Logan RF; Rainbow S; Smith S; Thomas M; Counsell N; von Wagner C
BMC Cancer; 2017 Aug; 17(1):543. PubMed ID: 28806955
[TBL] [Abstract][Full Text] [Related]
7. Comment on 'Reasons for non-uptake and subsequent participation in the NHS bowel cancer screening programme: a qualitative study'.
Tai CK; Leung P; Poullis A; Curry G
Br J Cancer; 2015 May; 112(11):1834. PubMed ID: 25356805
[No Abstract] [Full Text] [Related]
8. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England.
Moss S; Mathews C; Day TJ; Smith S; Seaman HE; Snowball J; Halloran SP
Gut; 2017 Sep; 66(9):1631-1644. PubMed ID: 27267903
[TBL] [Abstract][Full Text] [Related]
9. What affects the uptake of screening for bowel cancer using a faecal occult blood test (FOBt): a qualitative study.
Chapple A; Ziebland S; Hewitson P; McPherson A
Soc Sci Med; 2008 Jun; 66(12):2425-35. PubMed ID: 18358581
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing participation in colorectal cancer screening-a qualitative study in an ethnic and socio-economically diverse inner city population.
Dharni N; Armstrong D; Chung-Faye G; Wright AJ
Health Expect; 2017 Aug; 20(4):608-617. PubMed ID: 27550367
[TBL] [Abstract][Full Text] [Related]
11. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
[TBL] [Abstract][Full Text] [Related]
12. Concerns, perceived need and competing priorities: a qualitative exploration of decision-making and non-participation in a population-based flexible sigmoidoscopy screening programme to prevent colorectal cancer.
Hall N; Birt L; Rees CJ; Walter FM; Elliot S; Ritchie M; Weller D; Rubin G
BMJ Open; 2016 Nov; 6(11):e012304. PubMed ID: 27836872
[TBL] [Abstract][Full Text] [Related]
13. Piloting the Impact of Three Interventions on Guaiac Faecal Occult Blood Test Uptake within the NHS Bowel Cancer Screening Programme.
White B; Power E; Ciurej M; Lo SH; Nash K; Ormiston-Smith N
Biomed Res Int; 2015; 2015():928251. PubMed ID: 26525423
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the effectiveness of GP endorsement on increasing participation in the NHS Bowel Cancer Screening Programme in England: study protocol for a randomized controlled trial.
Damery S; Smith S; Clements A; Holder R; Nichols L; Draper H; Clifford S; Parker L; Hobbs R; Wilson S
Trials; 2012 Feb; 13():18. PubMed ID: 22348399
[TBL] [Abstract][Full Text] [Related]
15. Predictors of repeat participation in the NHS bowel cancer screening programme.
Lo SH; Halloran S; Snowball J; Seaman H; Wardle J; von Wagner C
Br J Cancer; 2015 Jan; 112(1):199-206. PubMed ID: 25429524
[TBL] [Abstract][Full Text] [Related]
16. Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials.
Wardle J; von Wagner C; Kralj-Hans I; Halloran SP; Smith SG; McGregor LM; Vart G; Howe R; Snowball J; Handley G; Logan RF; Rainbow S; Smith S; Thomas MC; Counsell N; Morris S; Duffy SW; Hackshaw A; Moss S; Atkin W; Raine R
Lancet; 2016 Feb; 387(10020):751-9. PubMed ID: 26680217
[TBL] [Abstract][Full Text] [Related]
17. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
Todorov K; Wilson C; Sharplin G; Corsini N
Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes.
Mead L; Porteous L; Tait M; Stoker R; Payne S; Calvert C; Maxwell D; Katikireddi SV
J Med Screen; 2015 Jun; 22(2):106-8. PubMed ID: 25753487
[TBL] [Abstract][Full Text] [Related]
19. Patient factors associated with non-attendance at colonoscopy after a positive screening faecal occult blood test.
Plumb AA; Ghanouni A; Rainbow S; Djedovic N; Marshall S; Stein J; Taylor SA; Halligan S; Lyratzopoulos G; von Wagner C
J Med Screen; 2017 Mar; 24(1):12-19. PubMed ID: 27216771
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
